Quadrant Capital Group LLC Akouos, Inc. Transaction History

Quadrant Capital Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.46 - $5.2 $4,095 - $8,658	-1,665 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$4.16 - $9.08 $1,772 - $3,868	426 Added 34.38%	1,665 $8,000
Q4 2021 Feb 01, 2022	BUY	$7.65 - $11.38 $9,371 - $13,940	1,225 Added 8750.0%	1,239 $11,000
Q3 2021 Nov 12, 2021	SELL	$9.93 - $13.59 $119 - $163	-12 Reduced 46.15%	14 $0
Q2 2021 Aug 09, 2021	BUY	$11.87 - $15.96 $308 - $414	26 New	26 $0

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.